SILVERARC CAPITAL MANAGEMENT, LLC Trevi Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$1.44M
portfolio value

Trevi Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 939.26K shares 1.44M $1.54 939.26K